← Eichor
Study identifier: NCT06791941 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer

Condition: Head and Neck Tumors  ·  Sponsor: Regina Elena Cancer Institute

PhaseN/A
Planned participants18
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Multicenter, non-interventional, retrospective/prospective study of a biological nature, on patients affected by head and neck tumors, for which the collection and use of tissue samples is planned for the study of the mutational profile, the transcriptional profile and the proteomic profile.

This description comes directly from the study's public registry record.

Talk to the study team

Giovanni Blandino, Doctor  ·  +39 06 52662911  ·  giovanni.balndino@ifo.it

Always discuss trial participation with your own doctor first.

Locations (1)

IRCCS National Cancer instituteRoma, Rome, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06791941